A CONVERSATION WITH… Isabelle de Cremoux, CEO and Managing Partner of European Life Science VC Seventure Partners

Abstract

Inside Precision MedicineVol. 9, No. 2 In Conversation WithA CONVERSATION WITH… Isabelle de Cremoux, CEO and Managing Partner of European Life Science VC Seventure PartnersBacking the Microbiome: The Investor PerspectiveHelen AlbertHelen AlbertHelen Albert is Senior Editor at Inside Precision Medicine and a freelance science journalist. Prior to going freelance, she was Editor-in-Chief at Labiotech, an English-language, digital publication based in Berlin focusing on the European biotech industry. Before moving to Germany, she worked at a range of different science and health-focused publications in London. She was Editor of The Biochemist magazine and blog, but also worked as a Senior Reporter at Springer Nature's medwireNews for a number of years, as well as freelancing for various international publications. She has written for New Scientist, Chemistry World, Biodesigned, The BMJ, Forbes, Science Business, Cosmos magazine, and GEN. Helen has academic degrees in genetics and anthropology, and also spent some time early in her career working at the Sanger Institute in Cambridge before deciding to move into journalism.Senior EditorSearch for more papers by this authorPublished Online:14 Apr 2022https://doi.org/10.1089/ipm.09.02.14AboutSectionsView articleView Full TextPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View articleFiguresReferencesRelatedDetails Volume 9Issue 2Apr 2022 InformationCopyright © GEN PublishingTo cite this article:Helen Albert.A CONVERSATION WITH… Isabelle de Cremoux, CEO and Managing Partner of European Life Science VC Seventure Partners.Inside Precision Medicine.Apr 2022.50-52.http://doi.org/10.1089/ipm.09.02.14Published in Volume: 9 Issue 2: April 14, 2022PDF download